However, the upregulation of ten–eleven translocation methylcytosine dioxygenase 1 (TET1) has been reported to suppress tumor cell survival, migration, and invasion via the activation of Wnt antagonist, dishevelled binding antagonist of beta catenin 2 (DACT2), and SFRP2. The gene discussed is SFRP2; the disease is neoplasm.